Drug interaction between St John's wort and nevirapine

AIDS

Volumn 15, Issue 3, 2001, Pages 420-421

  De Maat, Monique M R ^a   Hoetelmans, Richard M W ^a   Mathôt, Ron A A ^a   Van Gorp, Eric C M ^a   Meenhorst, Pieter L ^a   Mulder, Jan W ^a   Beijnen, Jos H ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG CLEARANCE; ENZYME INDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; HYPERICUM; MALE; MIDDLE AGED; NEVIRAPINE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0035895667     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200102160-00019     Document Type: Article

References (7)

1. Biologically active and other chemical constituents of the herb of Hypericum perforatum L
2. Indinavir concentrations and St John's wort
3. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
4. Second thoughts about safety of St John's wort
5. Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients
6. High exposure to nevirapine is associated with a higher initial HIV-1 clearance rate, a higher likelihood to reach undetectability and prolonged suppression of HIV-1 replication